Capacity Assessment in Persons With Alzheimer's Disease (MACAP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01190800|
Recruitment Status : Completed
First Posted : August 30, 2010
Last Update Posted : October 15, 2014
|Condition or disease|
|Alzheimer's Disease Capacity to Consent to Treatment Capacity to Vote Capacity to Design a Proxy|
Study of Alzheimer's disease patients show a wide variability in decision-making abilities, especially for the consent to treatment and the ability to vote. No tools are available to assess the capacity to design a proxy. The purpose of this research is to assess simultaneously four decision-making abilities in persons with Alzheimer's disease: the capacity to consent to treatment, the capacity to vote and the capacity to design a proxy either to consent to treatment or to vote.
This study will recruit 320 patients with Alzheimer's disease and 80 non-demented control subjects. Four decision-making questionnaires will be administered to participants to explore participant capacity to understand, reason, appreciate and make a choice about the capacity to consent to treatment, to vote and to design a proxy either to consent to treatment or to vote. Once validated in the first part of this research, the questionnaires will be used to study decision-making abilities and their determinants in patients with Alzheimer's disease and control subjects.
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||Decision Capacity Assessment in Persons With Alzheimer's Disease: Approach by Capacity to Appoint a Proxy, to Consent to Treatment and to Vote|
|Study Start Date :||June 2010|
|Actual Primary Completion Date :||September 2014|
|Actual Study Completion Date :||September 2014|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01190800
|Hôpital Louis Mourier|
|Colombes, France, 92700|
|Principal Investigator:||Antoine Bosquet, MD||Assistance Publique - Hôpitaux de Paris|